Back
Hikma Pharmaceuticals PLC Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison
Sell
48
HKMPY
Hikma Pharmaceuticals PLC
Last Price:
48.85
Seasonality Move:
-0.03%
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
4.24
Seasonality Move:
-7.83%
Sell
48
Hikma Pharmaceuticals PLC (HKMPY)
is a Sell
Is Hikma Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Hikma Pharmaceuticals PLC [HKMPY] share price is $50.32. The Score for HKMPY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- HKMPY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals PLC [BDRX] share price is $4.43. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
HKMPY Stock Price Chart
What is Hikma Pharmaceuticals PLC's stock price today?
-
The Hikma Pharmaceuticals PLC share price today is $50.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HKMPY is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $4.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing selling pressure, which indicates risk of future bearish movement.
HKMPY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 54.67 | Buy |
| Chaikin Money Flow: | 370 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.8 - 50.64) | Buy |
| Bollinger Bands (100): | (48.05 - 52.45) | Buy |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 41.14 | Sell |
| Chaikin Money Flow: | -19988 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.15 - 5.53) | Sell |
| Bollinger Bands (100): | (0.38 - 5.42) | Buy |
HKMPY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.22 | Buy |
| 20-day SMA: | 49.16 | Buy |
| 50-day SMA: | 49.41 | Buy |
| 200-day SMA: | 49.54 | Buy |
| 8-day EMA: | 50.08 | Buy |
| 20-day EMA: | 49.59 | Buy |
| 50-day EMA: | 49.53 | Buy |
| 200-day EMA: | 49.48 | Buy |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.05 | Sell |
| 20-day SMA: | 4.75 | Sell |
| 50-day SMA: | 5.29 | Sell |
| 200-day SMA: | 1.98 | Buy |
| 8-day EMA: | 4.8 | Sell |
| 20-day EMA: | 4.93 | Sell |
| 50-day EMA: | 4.51 | Sell |
| 200-day EMA: | 11.28 | Sell |
Hikma Pharmaceuticals PLC Earnings Growth & HKMPY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.05 per share.
Hikma Pharmaceuticals PLC Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals PLC Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||